SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-088597
Filing Date
2023-08-08
Accepted
2023-08-08 07:23:37
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2323052d1_10ka.htm   iXBRL 10-K/A 45768
2 EXHIBIT 31.1 tm2323052d1_ex31-1.htm EX-31.1 10309
3 EXHIBIT 31.2 tm2323052d1_ex31-2.htm EX-31.2 9877
  Complete submission text file 0001104659-23-088597.txt   341912

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA trda-20221231.xsd EX-101.SCH 3321
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trda-20221231_def.xml EX-101.DEF 28313
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE trda-20221231_lab.xml EX-101.LAB 38620
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trda-20221231_pre.xml EX-101.PRE 26956
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2323052d1_10ka_htm.xml XML 7835
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40969 | Film No.: 231149323
SIC: 2834 Pharmaceutical Preparations